HIV adherence survey findings at a glance
HIV adherence survey findings at a glance
Study highlights medication problems
The recently released "Survey on Treatment Adherence by HIV+ People," conducted by Savitz Research in Chicago, shows that 62% of those surveyed who are taking antiretroviral drugs find it difficult to adhere to their drug regimen.
The survey, which used a written questionnaire by National Family Opinion and which was funded by GlaxoSmithKline of Research Triangle Park, NC, involved 371 total HIV-positive respondents out of a database of 2,500 households that have an HIV-positive member. The average time survey respondents had been on antiretroviral drugs was six years and seven months, with 9% on therapy for less than two years and 28% on therapy for 10 years or longer. The sample surveyed is not necessarily representative of all HIV-positive individuals, but it does shed light on why HIV drug adherence has become such a hurdle to therapy success. Here are some of the key findings:
• The top reason cited for patients failing to comply with their treatment each day is "too many pills," which was listed by 67% of respondents. This is followed by side effects (61%), food restrictions (55%), frequency of having to take pills (49%), and timetable for having to take the pills (48%). Cost was listed as an obstacle by only 1%.
• When asked what would be the most important change to make it easier to take HIV drugs, 93% of the respondents who are taking HIV drugs said they would like to see a change in how the drugs are administered. Their top three choices for administration changes are to have a reduction in the number of times they need to take the pills, having fewer pills to take, and having a single pill rather than multiple pills.
• When asked what would be the most important characteristic of a better HIV drug, 67% again cited administration changes, and 64% said a reduction in the side effects.
• Participants were asked when it became difficult for them to take their drug plan, and 43% said after the first year; 21% said after the first day; 15% said after the first month; and 7% said after the first week.
• The survey asked patients how their physician prepared or educated them about the treatment program, and 25% said no preparation was given; 22% said the physician explained administration issues; 20% said the physician explained how the medication worked; 14% said the physician explained side effects; 23% said the physician answered their questions; 10% said the physician provided reading materials; and 4% said the physician referred them to another professional.
• Only 64% said they had felt mentally prepared to start their anti-HIV drug plan.
• When asked which side effects of anti-HIV/AIDS drugs concerned them most, 56% said gastrointestinal problems, 26% said organ problems, and 16% said weakness/fatigue. Other problems cited included weight change, headache/ dizziness, drug interaction, psychological problems, loss of appetite, skin problems, aches/pains, neuropathy, toxicity, lipodystrophy, sickness, body deformities, blindness, and numbness/tingling.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.